Novel hemostatic nephrostomy tube

Area of Science:

• Urology
• Surgical Innovation

Background:

• Percutaneous renal surgery, including percutaneous nephrostolithomy, carries a risk of significant hemorrhage from the access site.
• Managing post-operative bleeding from percutaneous renal access sites can be challenging.

Purpose of the Study:

• To introduce and evaluate a novel nephrostomy tube designed to prevent and manage hemorrhage from percutaneous renal surgery access sites.
• To assess the safety, efficacy, and tolerability of this new device in high-risk patients.

Main Methods:

• Development of a novel nephrostomy tube integrating re-entry Malecot design principles with Kaye tamponade catheter features.
• Placement of the novel tube in high-risk patients following percutaneous nephrostolithomy.
• Evaluation of the tube's effectiveness in controlling bleeding and maintaining ureteral access.
• Assessment of patient tolerance and complication rates.

Main Results:

• The novel nephrostomy tube successfully prevented significant bleeding in all high-risk patients.
• The device was well-tolerated by patients, with no reported complications.
• The tube demonstrated ease of insertion and effectiveness in both preventing and stopping hemorrhage.
• Ureteral access was successfully maintained throughout the treatment period.

Conclusions:

• The novel combined Malecot-Kaye nephrostomy tube is a safe and effective solution for managing bleeding complications after percutaneous renal surgery.
• This innovative device offers a promising approach to enhance patient safety and outcomes in percutaneous nephrostolithomy.
• The preliminary results support the use of this tube for its hemostatic properties and ability to maintain ureteral patency.